Michele Fusaroli

1.4k total citations
45 papers, 562 citations indexed

About

Michele Fusaroli is a scholar working on Toxicology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Michele Fusaroli has authored 45 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Toxicology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Michele Fusaroli's work include Pharmacovigilance and Adverse Drug Reactions (18 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Drug-Induced Adverse Reactions (4 papers). Michele Fusaroli is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (18 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Drug-Induced Adverse Reactions (4 papers). Michele Fusaroli collaborates with scholars based in Italy, France and Sweden. Michele Fusaroli's co-authors include Emanuel Raschi, Elisabetta Poluzzi, Fabrizio De Ponti, Andrea Ardizzoni, Milo Gatti, Paolo Caraceni, Manfred Hauben, Marco Menchetti, Andrea De Giglio and Claudio Zamagni and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Neurology.

In The Last Decade

Michele Fusaroli

40 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michele Fusaroli Italy 13 184 155 131 67 65 45 562
Sophie Fédrizzi France 13 358 1.9× 172 1.1× 65 0.5× 57 0.9× 33 0.5× 49 727
Takahiro Niimura Japan 13 207 1.1× 134 0.9× 42 0.3× 29 0.4× 36 0.6× 67 517
Birgitta Grundmark Sweden 13 95 0.5× 98 0.6× 201 1.5× 89 1.3× 17 0.3× 18 593
Diogo Mendes Portugal 16 129 0.7× 68 0.4× 92 0.7× 96 1.4× 21 0.3× 40 796
Giuseppe Roberto Italy 15 117 0.6× 108 0.7× 108 0.8× 46 0.7× 14 0.2× 50 726
Cindy Kortepeter United States 15 139 0.8× 41 0.3× 97 0.7× 117 1.7× 19 0.3× 30 787
Christian Leporini Italy 14 116 0.6× 54 0.3× 101 0.8× 54 0.8× 41 0.6× 24 715
Mayako Uchida Japan 14 218 1.2× 72 0.5× 51 0.4× 49 0.7× 35 0.5× 94 508
Gabriella di Mauro Italy 14 73 0.4× 45 0.3× 80 0.6× 64 1.0× 30 0.5× 32 671
Marie‐Christine Pérault‐Pochat France 9 136 0.7× 47 0.3× 105 0.8× 59 0.9× 11 0.2× 21 394

Countries citing papers authored by Michele Fusaroli

Since Specialization
Citations

This map shows the geographic impact of Michele Fusaroli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Fusaroli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Fusaroli more than expected).

Fields of papers citing papers by Michele Fusaroli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Fusaroli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Fusaroli. The network helps show where Michele Fusaroli may publish in the future.

Co-authorship network of co-authors of Michele Fusaroli

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Fusaroli. A scholar is included among the top collaborators of Michele Fusaroli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Fusaroli. Michele Fusaroli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fusaroli, Michele, Daniele Sartori, Eugène van Puijenbroek, & G. Niklas Norén. (2025). Charting and Sidestepping the Pitfalls of Disproportionality Analysis. Drug Safety. 49(2). 147–162. 1 indexed citations
3.
Fusaroli, Michele, Charles Khouri, Elisabetta Poluzzi, et al.. (2024). Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports. Journal of Clinical Psychopharmacology. 44(4). 443–444. 2 indexed citations
4.
Fusaroli, Michele, Francesco Salvo, Charles Khouri, & Emanuel Raschi. (2024). The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline. Frontiers in Pharmacology. 15. 1488725–1488725. 7 indexed citations
5.
Fusaroli, Michele, et al.. (2024). Environmental sustainability—an essential component of rational use of medicines. International Journal of Pharmacy Practice. 33(1). 102–112. 1 indexed citations
6.
Fusaroli, Michele, Emanuel Raschi, Elisabetta Poluzzi, & Manfred Hauben. (2024). The evolving role of disproportionality analysis in pharmacovigilance. Expert Opinion on Drug Safety. 23(8). 981–994. 25 indexed citations
7.
Fusaroli, Michele, Vera Battini, Charles Khouri, et al.. (2024). Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS. Drug Safety. 47(3). 271–284. 9 indexed citations
8.
Fusaroli, Michele, Arndis Simonsen, Stephanie A. Borrie, et al.. (2023). Identifying Medications Underlying Communication Atypicalities in Psychotic and Affective Disorders: A Pharmacovigilance Study Within the FDA Adverse Event Reporting System. Journal of Speech Language and Hearing Research. 66(9). 3242–3259. 7 indexed citations
9.
Fusaroli, Michele, Guido Pelletti, Emanuel Raschi, et al.. (2023). Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System. Drug Safety. 46(3). 283–295. 7 indexed citations
10.
Vitale, Giovanni, Michele Fusaroli, Mattia Riefolo, et al.. (2023). Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors. JTO Clinical and Research Reports. 4(9). 100563–100563. 9 indexed citations
11.
Raschi, Emanuel, et al.. (2023). Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians. Drug Safety. 46(9). 819–833. 24 indexed citations
12.
Raschi, Emanuel, Michele Fusaroli, Francesco Massari, et al.. (2022). The Changing Face of Drug-induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System. The Journal of Clinical Endocrinology & Metabolism. 107(8). e3107–e3114. 12 indexed citations
13.
Fusaroli, Michele, Valentina Isgrò, Paola Maria Cutroneo, et al.. (2022). Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database. Drug Safety. 45(8). 891–908. 40 indexed citations
14.
Fusaroli, Michele, Emanuel Raschi, Elisa Baldin, et al.. (2022). Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System. Drug Safety. 45(6). 663–673. 8 indexed citations
15.
Fusaroli, Michele, Vera Battini, Roberto Rimondini, et al.. (2022). Exploring the underlying mechanisms of drug‐induced impulse control disorders: a pharmacovigilance‐pharmacodynamic study. Psychiatry and Clinical Neurosciences. 77(3). 160–167. 12 indexed citations
16.
Fusaroli, Michele, Luca Pellegrini, Riccardo Fusaroli, et al.. (2022). Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the ‘impulse control disorders’ diagnostic construct. Addiction. 118(4). 763–770. 3 indexed citations
17.
Fusaroli, Michele, Emanuel Raschi, Manuela Contin, et al.. (2021). Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list. Parkinsonism & Related Disorders. 90. 79–83. 7 indexed citations
18.
Gatti, Milo, Stefano Cavalieri, Michele Fusaroli, et al.. (2021). Bone fracture as a novel immune‐related adverse event with immune checkpoint inhibitors: Case series and large‐scale pharmacovigilance analysis. International Journal of Cancer. 149(3). 675–683. 27 indexed citations
19.
Aiello, Valeria, Michele Fusaroli, Emanuel Raschi, et al.. (2021). Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry. Kidney International Reports. 6(9). 2472–2477. 4 indexed citations
20.
Iommi, Marica, Simona Rosa, Michele Fusaroli, et al.. (2020). Modified-Chronic Disease Score (M-CDS): Predicting the individual risk of death using drug prescriptions. PLoS ONE. 15(10). e0240899–e0240899. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sophie Fédrizzi Breakdown of academic impact, for papers by Takahiro Niimura Breakdown of academic impact, for papers by Birgitta Grundmark Breakdown of academic impact, for papers by Diogo Mendes Breakdown of academic impact, for papers by Giuseppe Roberto Breakdown of academic impact, for papers by Cindy Kortepeter Breakdown of academic impact, for papers by Christian Leporini Breakdown of academic impact, for papers by Mayako Uchida Breakdown of academic impact, for papers by Gabriella di Mauro Breakdown of academic impact, for papers by Marie‐Christine Pérault‐Pochat
Rankless by CCL
2026